| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,617 |
8,014 |
$2.43M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,176 |
11,481 |
$2.26M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,293 |
1,166 |
$526K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,549 |
2,429 |
$256K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,333 |
3,086 |
$82K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
14,425 |
13,193 |
$69K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,483 |
2,352 |
$57K |
| 80053 |
Comprehensive metabolic panel |
8,254 |
7,423 |
$35K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,720 |
2,503 |
$27K |
| 87276 |
|
2,605 |
2,481 |
$16K |
| 87275 |
|
2,606 |
2,482 |
$15K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
5,063 |
4,344 |
$14K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,023 |
953 |
$10K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
15 |
13 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
863 |
789 |
$6K |
| 36415 |
Collection of venous blood by venipuncture |
1,829 |
1,545 |
$5K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
485 |
451 |
$4K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
771 |
702 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
17 |
13 |
$4K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
26 |
26 |
$4K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
431 |
403 |
$3K |
| 83690 |
|
895 |
832 |
$3K |
| 71046 |
Radiologic examination, chest; 2 views |
298 |
277 |
$3K |
| 84484 |
|
255 |
231 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
314 |
295 |
$3K |
| 81003 |
|
828 |
755 |
$2K |
| 81001 |
|
2,185 |
2,027 |
$2K |
| 80061 |
Lipid panel |
317 |
297 |
$1K |
| 86140 |
|
102 |
96 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
150 |
144 |
$985.20 |
| 84443 |
Thyroid stimulating hormone (TSH) |
211 |
196 |
$952.47 |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
25 |
24 |
$931.68 |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
14 |
12 |
$690.85 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,296 |
1,172 |
$616.00 |
| 87081 |
|
129 |
123 |
$475.02 |
| 82728 |
|
151 |
143 |
$424.31 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
13 |
12 |
$340.38 |
| 81025 |
|
104 |
95 |
$301.96 |
| 83735 |
|
86 |
79 |
$281.87 |
| 84466 |
|
124 |
117 |
$268.99 |
| 84703 |
|
74 |
71 |
$246.83 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
13 |
12 |
$196.44 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
51 |
49 |
$167.40 |
| 83540 |
|
124 |
117 |
$136.35 |
| 70450 |
Computed tomography, head or brain; without contrast material |
26 |
25 |
$91.22 |
| 84439 |
|
54 |
50 |
$84.43 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
68 |
63 |
$22.37 |
| 85610 |
|
13 |
13 |
$7.72 |
| A9270 |
Non-covered item or service |
77 |
63 |
$0.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
999 |
928 |
$0.00 |